Boudreaux Gail's Form 4 filing
Elevance Health, Inc. (ELV) · filed Jul 18, 2025
- Accession no.
- 0001287920-25-000005
- Filed
- Jul 18, 2025
- Trade date
- Jul 18, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.44M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boudreaux GailCIK 0001287920 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2025 | Common Stock | PPurchaseAcquired | +2,334 | $286.07 | +$667,687.38 | 144,854 | Direct | |
| Jul 18, 2025 | Common Stock | PPurchaseAcquired | +5,116 | $287.12 | +$1,468,905.92 | 149,970 | Direct | |
| Jul 18, 2025 | Common Stock | PPurchaseAcquired | +1,050 | $287.96 | +$302,358 | 151,020 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.